Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
20,908,887
-
Total 13F shares
-
1,351,642
-
Share change
-
+249,793
-
Total reported value
-
$5,500,530
-
Price per share
-
$4.07
-
Number of holders
-
13
-
Value change
-
+$1,016,457
-
Number of buys
-
10
-
Number of sells
-
1
Institutional Holders of Coya Therapeutics, Inc. - Common Stock, $0.0001 par value per share (COYA) as of Q2 2023
As of 30 Jun 2023,
Coya Therapeutics, Inc. - Common Stock, $0.0001 par value per share (COYA) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,351,642 shares.
The largest 10 holders included
AIGH Capital Management LLC, GREENLIGHT CAPITAL INC, Worth Venture Partners, LLC, CM Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, BANK OF AMERICA CORP /DE/, UBS Group AG, Mirador Capital Partners LP, CITADEL ADVISORS LLC, and BlackRock Inc..
This page lists
13
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.